Clinical Trial Update: Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1) [Phase 2]

View source ↗

Summary

A Phase 2 trial (ALPESTRIA-1) evaluated the safety and efficacy of vonafexor for Alport Syndrome and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Syndrome

Drugs mentioned

• Vonafexor (vonafexor)

Snippet

Sponsor: Enyo Pharma | Conditions: Alport Syndrome | Phase 2 | Status: COMPLETED